Global Markets
Zealand Pharma (ZEAL DC) targets 10 new clinical programmes by 2030 focused on metabolic health, according to remarks at a Jefferies conference
ORIGINAL · NewsquawkZealand Pharma (ZEAL DC) targets 10 new clinical programmes by 2030 focused on metabolic health, according to remarks at a Jefferies conference
StockNow breaking-news AI analysis
Zealand Pharma reiterated a target of 10 metabolic-health clinical programmes by 2030, a goal its November 12 update linked to expanded research capabilities and a growing pipeline.
What do investors think?
Curious what other investors think?Log in to see reactions and join the conversation.
Log in to view reactionsStockNow uses AI to translate and analyze information and does not guarantee its accuracy or completeness.
